• LGK-974: PORCN Inhibitor Workflows for Wnt-Driven Cancer Res

  2026-06-03

  LGK-974, a potent and selective PORCN inhibitor, empowers researchers to dissect Wnt signaling with nanomolar precision in complex cancer models. This guide translates bench-validated workflows, troubleshooting strategies, and protocol enhancements for robust mechanistic studies, especially in Wnt-dependent and RNF43-mutant pancreatic cancer systems.

• MRT68921: Precision ULK1 Kinase Inhibition for Autophagy Res

  2026-06-03

  MRT68921 stands out as a nanomolar-potent ULK1/2 kinase inhibitor, enabling researchers to dissect autophagy signaling with unprecedented specificity. This article details optimized workflows, troubleshooting strategies, and cutting-edge applications, highlighting how MRT68921 from APExBIO empowers both mammalian and aquaculture autophagy studies.

• Selective SGLT-2 Inhibitors Protect the Heart: Mechanistic I

  2026-06-02

  The referenced study provides a rigorous comparison of selective SGLT-2 inhibitors—empagliflozin, dapagliflozin, and ertugliflozin—in a non-diabetic mouse model of myocardial ischemia/reperfusion injury. It delineates drug- and class-specific cardioprotective mechanisms, revealing that empagliflozin and dapagliflozin reduce infarct size via STAT-3 and PI3K-dependent pathways, independent of SGLT-2 inhibition, with implications for translational research into mitochondrial and apoptotic signaling.

• GW4064: Non-Steroidal FXR Agonist for Advanced Metabolic Stu

  2026-06-02

  GW4064 empowers metabolic researchers with precise FXR activation, enabling dissection of bile acid, cholesterol, and triglyceride regulation. Its application in FXR/TLR4/ferroptosis pathway models, as evidenced by recent studies, unlocks novel mechanistic insights and robust experimental workflows.

• Thiamet G: Precision O-GlcNAcase Inhibition in Bone and Brai

  2026-06-01

  Explore how Thiamet G, a potent O-GlcNAcase inhibitor, uniquely advances research into O-GlcNAcylation in osteogenesis and neurodegeneration. This article delivers a mechanistic deep dive and actionable protocol guidance for translational disease models.

• Tin Mesoporphyrin IX: Precision Inhibition for Heme Oxygenas

  2026-06-01

  Tin Mesoporphyrin IX (chloride) offers bench researchers unique, high-affinity inhibition of heme oxygenase activity, enabling advanced studies in metabolic and virology models where heme catabolism is central. This guide delivers actionable protocols and troubleshooting insights, translating recent mechanistic findings into practical experimental workflows.

• Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP): Applied Workflo

  2026-05-31

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) enables robust, reproducible bioluminescent assays across gene expression, cell viability, and in vivo imaging. Built on advanced cap analog and nucleotide modifications, this mRNA empowers researchers to optimize transfection, reduce innate immune activation, and achieve consistent results—even in challenging workflows.

• Bismuth Subsalicylate in Apoptosis Assays: Beyond GI Models

  2026-05-30

  Explore the unique role of Bismuth Subsalicylate in apoptosis and membrane integrity research. This article reveals advanced assay strategies and mechanistic insights, setting it apart from conventional gastrointestinal disorder research.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-05-29

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) enable efficient isolation and purification of biotinylated molecules from complex samples, reducing nonspecific binding and streamlining magnetic separation workflows. They are optimal for immunoprecipitation, protein interaction studies, and nucleic acid purification, but are not recommended for atypical or untested sample matrices without further validation.

• DDX23 Restricts SVA via Caspase Pathways: Mechanistic Insigh

  2026-05-29

  This study elucidates how host DEAD-box helicase 23 (DDX23) restricts Senecavirus A (SVA) replication through targeted degradation of viral proteins via apoptosis-related caspase pathways. The dual mechanism uncovered offers new avenues for antiviral strategy design and enhances our understanding of host-pathogen interplay in RNA virus infections.

• Dasatinib Monohydrate in Complex Tumor Microenvironments: Ad

  2026-05-28

  Explore how Dasatinib Monohydrate (BMS-354825) shapes kinase inhibitor research in physiologically relevant tumor microenvironments. This in-depth analysis reveals insights for chronic myeloid leukemia research and beyond, grounded in recent advances in assembloid modeling.

• Super-Enhancer Regulation of KLF6 in Human Adipogenesis

  2026-05-28

  Nguyen et al. identify a super-enhancer (SE)-driven mechanism for KLF6 induction during adipogenesis of human adipose-derived stem cells (hADSCs). This study provides mechanistic insight into transcriptional regulation in adipocyte differentiation, with implications for metabolic and obesity-related research.

• ACE Inhibitor-Mediated Angioedema: Mechanisms and Clinical I

  2026-05-27

  This article examines the innovation and clinical insights from Montinaro and Cicardi’s study of ACE inhibitor-mediated angioedema (ACEi-AE). The paper clarifies the bradykinin-dependent pathogenesis, epidemiology, and therapeutic controversies of ACEi-AE, offering guidance for clinicians managing hypertension and comorbidities such as diabetes and heart disease. Implications for translational research and the interface with metabolic diseases are discussed.

• Applied Insights: Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP

  2026-05-27

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) from APExBIO streamlines bioluminescent reporter workflows by maximizing expression, minimizing immunogenicity, and enabling robust cross-platform controls. This article bridges experimental setup, advanced delivery optimization, and hands-on troubleshooting for reproducible, high-sensitivity gene expression assays.

• EZ Cap EGFP mRNA 5-moUTP: Advanced Reporter for Gene Express

  2026-05-26

  EZ Cap™ EGFP mRNA (5-moUTP) unlocks robust, immune-evasive gene expression and imaging workflows by leveraging Cap 1 capping and 5-methoxyuridine modifications. Explore optimized protocols, troubleshooting insights, and the latest advances in mRNA delivery for gene expression, all powered by APExBIO's trusted reagent.

16091 records 1/1073 page Next 12345 下5页 Last page